(trt) market to exceed $5.0 billion by 2017

Global Industry Analysts, Inc (GIA) announces the release of a comprehensive global report on Testosterone Replacement Therapy (TRT) market. Growing awareness among the affected population as well as physicians, aging population and the availability of wide range of treatment options is driving the TRT market to expand at a significant rate, with the market projected to surpass $5.0 billion by 2017.

San Jose, CA (PRWEB) April 26, 2011

The report profiles 25 companies including many key niche players such as Abbott Laboratories, Acrux Limited, Auxilium Pharmaceuticals, Inc.,

Full details can be found at the following webs:

http://www.prweb.com/releases/testosterone_replacement/therapy_TRT/prweb8338938.htm

http://www.strategyr.com/Testosterone_Replacement_Therapies_TRT_Market_Report.asp

----------------------------------------------------------

If we take $1.2B as current global market, $5B by 2017 equates to ~27% compound growth over 6 years. Pretty good potential growth in earnings for products that can hold good TRT market share over the term.